Select publications

Critz F et al. Simultaneous radiotherapy for prostate cancer: 125I prostate implant followed by externalbeam radiation. Cancer J Sci Am 1998;4(4):359-63. Abstract

Hanks G et al. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group protocol 92-02. J Clin Oncol 2003;21(21):3972-8. Erratum in: J Clin Oncol 2004;22(2):386. Abstract

Holm H. The history of interstitial brachytherapy of prostatic cancer. Semin Surg Oncol 1997;13(6):431-7. Abstract

Pilepich M et al. Androgen suppression adjuvant to radiotherapy in carcinoma of the prostate. Long-term results of Phase III RTOG study 85-31. Int J Radiat Oncol Biol Phys 2003;57(Suppl 2):172-3. Abstract

Pilepich M et al. Phase III trial of androgen suppression adjuvant to definitive radiotherapy. Long term results of RTOG study 85-31. Proc ASCO 2003; No abstract available.

Pollack A et al. Prostate cancer radiation dose response: Results of the M.D. Anderson Phase III randomized trial. Int J Radiat Oncol Biol Phys 2002;53(5):1097-105. Abstract

Roach M et al. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 2003;21:1904-11. Abstract

Rossi C. Conformal proton beam therapy of prostate cancer — Update on the Loma Linda University Medical Center experience. Strahlenther Onkol 1999;175(Suppl 2):82-4. Abstract

Sogani P et al. Experience with interstitial implantation of Iodine-125 in the treatment of prostatic carcinoma. Scand J Urol Nephrol Suppl 1980;55:205-11. Abstract